In the rapidly evolving subject of oncology investigation, accurate and effective mutation screening is essential for building targeted therapies. The KRAS expert services Platform performs a pivotal job During this landscape by offering extensive options for KRAS mutation profiling and Investigation. KRAS mutations, present in around 95% of RAS-re